CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: July 20, 2006
Result type: Reports
Project Number: SR0069-000
Product Line: Reimbursement Review

Generic Name: Sunitinib

Brand Name: Sutent

Manufacturer: Pfizer Canada Inc.

Therapeutic Area: Gastrointestinal stromal tumour (GIST)

Indications: Gastrointestinal stromal tumour (GIST)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 28, 2007

Recommendation Type: List with clinical criteria and/or conditions